Patent & IP news for July 30, 2013

Patent Litigations

USPTO Stats

6,118
published
appl'ns
4,017
granted
patents
64
ptab
decisions

Patent & IP Blogs

post image The America Invents Act Handbook: A Guide to the Patent Law Reform of 2011 from www.lotempiolaw.com

The landscape of American Patent law saw some major changes with the passage of the America Invents Act (AIA). In her newest book The America Invents Act Handbook: A Guide to the Patent Law Reform ...

Share via E–mail | Twitter | Facebook

post image Crocker doesn't come a cropper as application to transfer courts fails from patlit.blogspot.com

Crocker Enterprises Ltd v Giordano Poultry-Plast SpA is an extempore judgment of Mr Justice Mann (Patents Court, England and Wales) last month involving conditional fee arrangements and the transfer of proceedings between the expensive Patents ...

Share via E–mail | Twitter | Facebook

post image Note from AmeriKat: Mockingbirds, Model Orders and More Adwords Litigation from ipkitten.blogspot.com

The AmeriKat's Mockingbird
tote filled with stacks of
work and reading, and the
occasional squeaking snack
A London commuter may often spy the AmeriKat on her way to the City.  But it is not ...

Share via E–mail | Twitter | Facebook

post image Later evidence may be relied on in patent validity disputes -- but only just from ipkitten.blogspot.com

Some patent cases make this fairly non-technical Kat glaze over a bit when he tries to make head or tail of the facts. One such case is Generics [UK] Ltd (t/a Mylan) v Yeda ...

Share via E–mail | Twitter | Facebook

Federal Circuit Affirms Board Finding That Exclusion Of Genus Does Not Provide Written Description For Exclusion Of Species from www.pharmapatentsblog.com

In In Re Bimeda Research & Development Ltd., the Federal Circuit upheld the decision of the USPTO Patent Trial and Appeal Board (PTAB) that found that a claim that excluded the presence of a specific compound ...

Share via E–mail | Twitter | Facebook

Federal Circuit Affirms Board Finding That Exclusion Of Genus Does Not Provide Written Description For Exclusion Of Species from www.pharmapatentsblog.com

In In Re Bimeda Research & Development Ltd., the Federal Circuit upheld the decision of the USPTO Patent Trial and Appeal Board (PTAB) that found that a claim that excluded the presence of a specific compound ...

Share via E–mail | Twitter | Facebook

IP And Public Health, Biotech Rise As Issues In TPP Negotiations from www.ip-watch.org

Intellectual property and the issues of biotechnology and public health are rising concerns for stakeholders to the Trans-Pacific Partnership agreement negotiations. Related Articles:

Share via E–mail | Twitter | Facebook

What Does “Patent Pending” Mean? from inventivestep.net

I’m sure you’ve seen the words “patent pending” or “patent applied for” on a product or package before.  What exactly do these phrases mean?  What legal rights are attached to them? Marking Patentees ...

Share via E–mail | Twitter | Facebook

Henry Ford and ethanol from ipbiz.blogspot.com


Within US Patent 8,487,149, one finds the text:



Biofuels are renewable transportation fuels which have a long history ranging back to the beginning on the 20th century. As early as 1900, Rudolf Diesel ...

Share via E–mail | Twitter | Facebook

Patent Risk: The ‘New Normal’ In Patent Troll Litigation from www.ip-watch.org

New York - Financial companies in 2012 faced nearly four times the patent litigation from non-practicing entities (NPEs), often called “patent trolls”, than they did five years ago and 2013 promises to be no different, according ...

Share via E–mail | Twitter | Facebook

What Does “Patent Pending” Mean? from inventivestep.net

I’m sure you’ve seen the words “patent pending” or “patent applied for” on a product or package before.  What exactly do these phrases mean?  What legal rights are attached to them? Marking Patentees ...

Share via E–mail | Twitter | Facebook

Senators are concerned about abuse of standard-essential patents, looking past iPhone 4 import ban from www.fosspatents.com

I just watched the live webcast of today's hearing of the Subcommittee on Antitrust, Competition Policy and Consumer Rights of the Judiciary Committee of the United States Senate on "Standard Essential Patent [SEP] Disputes ...

Share via E–mail | Twitter | Facebook

Merging Burdens on Motions at Law in Patent Invalidity Cases from www.patentlyo.com

By Dennis Crouch Novozymes A/S v. DuPont Nutrition Biosciences (Fed. Cir. 2013) involved an interesting issue of the weight a judge should give to a jury decision on JNOV. In the case, a jury ...

Share via E–mail | Twitter | Facebook

Delay in Seeking TRO to Explore Potential License Undermines Plaintiff’s Claim of Irreparable Harm from docketreport.blogspot.com

The court denied plaintiffs' renewed motion for a TRO because plaintiffs' delay in seeking relief undermined their claim of irreparable harm. "Plaintiffs claim that [their] delay was attributable to failed negotiations between the parties following ...

Share via E–mail | Twitter | Facebook

Negative Claim Leads to "Udder" Failure from www.iplawalert.com

Judge Rich gave us the adage, “the name of the game is the claim.” Given the number of cases issued by the Federal Circuit on written description, perhaps the adage should be revised as “the ...

Share via E–mail | Twitter | Facebook

Infojustice: Setting The Record Straight On Fair Use In US from www.ip-watch.org

A paper examining the fair use doctrine in the United States, published by law professors Peter Jaszi and Matthew Sag and University of California at Berkeley fellow Gwen Hinze, addresses specific issues raised in an ...

Share via E–mail | Twitter | Facebook

EFPIA, PhRMA Release Joint Principles For Clinical Trial Data-Sharing, To Criticism from www.ip-watch.org

The European Federation of Pharmaceutical Industries and Associations (EFPIA) and the Pharmaceutical Research and Manufacturers of America (PhRMA) endorsed joint principles for clinical trial data-sharing. Related Articles:

Share via E–mail | Twitter | Facebook

Arrow misses target, but escitalopram is attacked with fresh Resolution from ipkitten.blogspot.com

Yesterday was a good day for Patents Court (England and Wales) judge Mr Justice Arnold. First, in Mylan v Yeda (noted here by the IPKat), his decision was upheld by a Court of Appeal containing ...

Share via E–mail | Twitter | Facebook

ITC Grants Motion To Terminate Respondents In Consolidated Enforcement and Modification Proceedings In Certain Dimmable Compact Fluorescent Lamps (337-TA-830) from www.itcblog.com

On July 26, 2013, the U.S. International Trade Commission issued a notice determining to grant motions to terminate  the consolidated enforcement and modification proceedings in Certain Dimmable Compact Fluorescent Lamps and Products (Inv. No ...

Share via E–mail | Twitter | Facebook

Board notes differences in independent claims and reverses some rejections while affirming others from allthingspros.blogspot.com

Takeaway: In an appeal involving disk drive controllers, the Board focused on differences between independent claims to reverse the obviousness rejection of several independent claims while affirming the rejection of another independent claim. The Board ...

Share via E–mail | Twitter | Facebook

Why Does Myriad Think It Can Win BRCA Gene Lawsuits? from www.patentdocs.org

By Kevin E. Noonan -- Earlier this month, Myriad Genetics filed patent infringement lawsuits against Ambry Genetics (on July 9th) and Gene-by-Gene (on July 10th). Filed with the complaint in the Ambry lawsuit was a Motion ...

Share via E–mail | Twitter | Facebook

Some content © 2007–2014 RPX Corporation.
Terms of Service & Privacy Policy
For DMCA requests contact help@priorsmart.com.